ID   HEV0012
AC   CVCL_T069
DR   CLO; CLO_0051213
DR   RCB; HEV0012
DR   Wikidata; Q54882933
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese and Korean.
CC   HLA typing: A*31:01,33:03; B*40:03,44:03; C*03:04,14:03; DPB1*05:01; DQB1*04:01,06:01; DRB1*04:05,08:03 (RCB=HEV0012).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
RX   PubMed=16260175; DOI=10.1016/j.mrgentox.2005.07.012;
RA   Iwakawa M., Goto M., Noda S., Sagara M., Yamada S., Yamamoto N.,
RA   Kawakami Y., Matsui Y., Miyazawa Y., Yamazaki H., Tsuji H., Ohno T.,
RA   Mizoe J., Tsujii H., Imai T.;
RT   "DNA repair capacity measured by high throughput alkaline comet assays
RT   in EBV-transformed cell lines and peripheral blood cells from cancer
RT   patients and healthy volunteers.";
RL   Mutat. Res. 588:1-6(2005).
//
RX   PubMed=38639832; DOI=10.1007/s13577-024-01055-0; PMCID=PMC11194210;
RA   Kasai F., Fukushima M., Miyagi Y., Nakamura Y.;
RT   "Genetic diversity among the present Japanese population: evidence
RT   from genotyping of human cell lines established in Japan.";
RL   Hum. Cell 37:944-950(2024).
//